Literature DB >> 17885241

Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging.

F Nelson1, A H Poonawalla, P Hou, F Huang, J S Wolinsky, P A Narayana.   

Abstract

BACKGROUND AND
PURPOSE: Accurate detection and classification of purely intracortical lesions in multiple sclerosis (MS) are important in understanding their role in disease progression and impact on the clinical manifestations of the disease. However, detection of these lesions with conventional MR imaging remains a challenge. Although double inversion recovery (DIR) has been shown to improve the sensitivity of the detection of cortical lesions, this sequence has low signal-to-noise ratio (SNR), poor delineation of lesion borders, and is prone to image artifacts. We demonstrate that intracortical lesions can be identified and classified with greater confidence by the combination of DIR with phase-sensitive inversion recovery (PSIR) images.
MATERIALS AND METHODS: A total of 16 subjects with MS were included in this study. DIR, PSIR, and fluid-attenuated inversion recovery (FLAIR) images were acquired and inspected by 3 experts, with identification of lesions by consensus. PSIR and DIR images were jointly used to classify lesions as purely intracortical, mixed gray-white matter, and juxtacortical. The difference in the number of lesions detected in each category was compared between combined PSIR and DIR and conventional FLAIR.
RESULTS: PSIR consistently allowed a clearer classification and delineation of lesions. Combined PSIR and DIR images showed a 337% improvement in the total number of lesions detected compared with FLAIR alone. Detection of intracortical lesions was improved by 417% compared with FLAIR. Detection of mixed gray-white matter and juxtacortical lesions was improved by 396% and 130%, respectively, compared with FLAIR.
CONCLUSION: Reliable detection and classification of intracortical lesions in MS are greatly improved by combined use of PSIR and DIR.

Entities:  

Mesh:

Year:  2007        PMID: 17885241      PMCID: PMC8134176          DOI: 10.3174/ajnr.A0645

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR.

Authors:  R H Lazeron; D W Langdon; M Filippi; J H van Waesberghe; V L Stevenson; J B Boringa; D Origgi; A J Thompson; M Falautano; C H Polman; F Barkhof
Journal:  Mult Scler       Date:  2000-08       Impact factor: 6.312

2.  The distribution of plaques in the cerebrum in multiple sclerosis.

Authors:  B BROWNELL; J T HUGHES
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-11       Impact factor: 10.154

3.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

4.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

5.  Grey matter abnormalities in multiple sclerosis: proton magnetic resonance spectroscopic imaging.

Authors:  R Sharma; P A Narayana; J S Wolinsky
Journal:  Mult Scler       Date:  2001-08       Impact factor: 6.312

6.  Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions.

Authors:  R Bakshi; S Ariyaratana; R H Benedict; L Jacobs
Journal:  Arch Neurol       Date:  2001-05

7.  Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging.

Authors:  Jeroen J G Geurts; Petra J W Pouwels; Bernard M J Uitdehaag; Chris H Polman; Frederik Barkhof; Jonas A Castelijns
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

8.  Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.

Authors:  Marco Rovaris; Marco Bozzali; Giuseppe Iannucci; Angelo Ghezzi; Domenico Caputo; Enrico Montanari; Antonio Bertolotto; Roberto Bergamaschi; Ruggero Capra; Giovanni Luigi Mancardi; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  Arch Neurol       Date:  2002-09

9.  Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration.

Authors:  L Bø; C A Vedeler; H Nyland; B D Trapp; S J Mørk
Journal:  Mult Scler       Date:  2003-08       Impact factor: 6.312

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  72 in total

Review 1.  MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Authors:  Frederik Barkhof; Jack H Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola de Stefano; Chris H Polman; John Petkau; Ernst W Radue; Maria P Sormani; David K Li; Paul O'Connor; Xavier Montalban; David H Miller; Massimo Filippi
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

Review 2.  Utility of double inversion recovery MRI in paediatric epilepsy.

Authors:  Bruno P Soares; Samuel G Porter; Amit M Saindane; Seena Dehkharghani; Nilesh K Desai
Journal:  Br J Radiol       Date:  2015-11-03       Impact factor: 3.039

Review 3.  Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 1-Mechanisms, Efficacy, and Safety.

Authors:  C McNamara; G Sugrue; B Murray; P J MacMahon
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-13       Impact factor: 3.825

Review 4.  Causes, effects and connectivity changes in MS-related cognitive decline.

Authors:  Carolina de Medeiros Rimkus; Martijn D Steenwijk; Frederik Barkhof
Journal:  Dement Neuropsychol       Date:  2016 Jan-Mar

Review 5.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

6.  In vivo detection of connectivity between cortical and white matter lesions in early MS.

Authors:  Jan-Mendelt Tillema; Stephen D Weigand; Jay Mandrekar; Yunhong Shu; Claudia F Lucchinetti; Istvan Pirko; John D Port
Journal:  Mult Scler       Date:  2016-10-03       Impact factor: 6.312

7.  2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Authors:  Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry
Journal:  J Magn Reson Imaging       Date:  2014-12-08       Impact factor: 4.813

8.  3D MPRAGE improves classification of cortical lesions in multiple sclerosis.

Authors:  F Nelson; A Poonawalla; P Hou; J S Wolinsky; P A Narayana
Journal:  Mult Scler       Date:  2008-11       Impact factor: 6.312

9.  Automated patient-specific optimization of three-dimensional double-inversion recovery magnetic resonance imaging.

Authors:  Refaat E Gabr; Xiaojun Sun; Amol S Pednekar; Ponnada A Narayana
Journal:  Magn Reson Med       Date:  2015-03-11       Impact factor: 4.668

10.  Optimizing 3D FLAIR to detect MS lesions: pushing past factory settings for precise results.

Authors:  Augustin Lecler; C Bouzad; R Deschamps; F Maizeroi; J C Sadik; A Gueguen; O Gout; H Picard; J Savatovsky
Journal:  J Neurol       Date:  2019-08-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.